Atlas FDA

TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™

FDA premarket approval P130026/S070 · decided 2021-11-04

Approval details

PMA number
P130026
Supplement
S070
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™
Generic name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Applicant
St Jude Medical
Date received
2021-04-01
Decision date
2021-11-04
Days to decision
217 days
Decision code
APPR
Product code
OAE
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Paul, MN
Statement
Approval for the TactiCath Contact Force Ablation Catheter, Sensor Enabled. The device is indicated for use in cardiac electrophysiology mapping and for the treatment of drug refractory recurrent symptomatic, paroxysmal, and persistent atrial fibrillation, when used in conjunction with a compatible RF generator and three-dimensional mapping system.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GuardianTM Burr Hole Cover System (K181382)St Jude Medical2018-07-20
EnSite Velocity Cardiac Mapping System v5.2 (K172396)St Jude Medical2018-04-23
myMerlin(TM) Mobile Application Model APP1001 (K173232)St Jude Medical2017-11-02
Advisor FL 15mm 12 Pole 333 Uni D, Advisor FL 20mm 12 Pole 555 Uni D, Advisor FL 15mm 12 Pole 333 Bi D, Advisor FL 20mm 12 Pole 555 Bi D (K160335)St Jude Medical2016-12-13
MediGuide Technology System (K162643)St Jude Medical2016-12-13
AutoMark Module (K160218)St Jude Medical2016-12-13
EnSite Precision Cardiac Mapping System v2.0 (K160210)St Jude Medical2016-12-13
Pacel Flow Directed Pacing Catheter (K161873)St Jude Medical2016-11-22